Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
A recent publication describes similar results with broad ActRIIA/B receptor blockade during GLP-1 RA-induced weight loss in obese mice, i.e., prevention of muscle loss with increased fat loss, resulting in multiple metabolic benefits 45
Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
For context, the dual agonist tirzepatide is studied in SURMOUNT ( NEJM , 2022) and SURMOUNT-OSA ( NEJM , 2024)
For more comprehensive information about peptides and their roles in health, consider trusted resources like the Health Wikipedia entry
One of the first questions many people ask is: Who are GLP-1 medications for
